Subjects with inflammatory diseases: without vasculitis (n=44) and with vasculitis (n=5)
| Receiving DMARD | ||||||||
|---|---|---|---|---|---|---|---|---|
| Disease | No | Mean age (range) | Not receiving DMARD | Prednisone | MTX | AZA | Etanercept | Combination |
| Rheumatoid arthritis | 21 | 46 (24–65) | 5 | 6 | 12 | 2 | 0 | 5 |
| Systemic lupus erythematosus | 8 | 33 (17–50) | 5 | 3 | 0 | 0 | 0 | 0 |
| Gout | 8 | 52 (34–70) | 7 | 1 | 0 | 0 | 0 | 0 |
| Spondyloarthropathy | 4 | 46 (39–58) | 1 | 0 | 2 | 0 | 1 | |
| Dermatomyositis | 2 | 49 (48–50) | 0 | 2 | 0 | 0 | 0 | 0 |
| Familial Mediterranean fever | 1 | 45 | 1 | 0 | 0 | 0 | 0 | 0 |
| Wegener's granulomatosis (ANCA +ve) | 1 | 86 M | Yes | – | – | – | – | – |
| Cutaneous vasculitis (with SLE) | 1 | 28 F | – | Yes | – | – | – | |
| Cryoglobulinaemic vasculitis (hepatitis C −ve) | 1 | 44 F | Yes | Yes | – | – | – | |
| Cryoglobulinaemic vasculitis (hepatitis C +ve) | 1 | 36 M | Yes | – | – | – | – | – |
| Cryoglobulinaemic vasculitis (hepatitis C +ve) | 1 | 43 M | Yes | – | – | – | – | – |